Rudolf Blankart, Dr. rer. pol., is professor of regulatory Affairs at the KPM Center for Public Management at the University of Bern and Director Promoting Services at sitem-insel AG, a public-private partnership in the field of translational medicine. He holds a master’s degree in Industrial Engineering from Technische Universität Berlin and a doctorate (PhD) from the Universität Hamburg both in Germany. Before being appointed at University of Bern (Switzerland), he held positions at Universität Hamburg and was visiting researcher at the Centre for Health Policy at Imperial College in London and at the Brown University School of Public Health in Providence, RI. Rudolf Blankart researches at the interface of medicine, management and law. In his research on health systems, he examines in particular the effects of regulatory measures on individual and systems level on costs, quality, and health outcomes. He also serves as a policy expert for national and international public and supranational organizations on the design of health systems.
Anand Parekh, M.D., MPH., is the Bipartisan Policy Center’s (BPC) chief medical advisor providing clinical and public health expertise across the organization. Prior to joining BPC, he completed a decade of service at the U.S. Department of Health and Human Services (HHS). As an HHS deputy assistant secretary for health from 2008 to 2015, he developed and implemented national initiatives focused on prevention, wellness, and care management. Briefly in 2007, he was delegated the authorities of the assistant secretary for health overseeing ten health program offices and the U.S. Public Health Service Commissioned Corps. Earlier in his HHS career, he played key roles in public health emergency preparedness efforts related to pandemic influenza and bioterrorism as special assistant to the science advisor to the secretary. Parekh is a board-certified internal medicine physician, a fellow of the American College of Physicians, an adjunct professor of health management and policy at the University of Michigan School of Public Health, and an adjunct assistant professor of medicine at Johns Hopkins University.
K.J. Seung, M.D., is chief of strategy and policy of the MA COVID Response for Partners In Health (PIH). He is also PIH’s co-leader for endTB (Expand New Drugs for TB), a multi-country clinical trial of novel short regimens for multidrug-resistant tuberculosis. KJ has extensive experience in clinical care, research, and innovative control programs for TB, HIV, and other diseases endemic in resource-limited settings. He is a board-certified physician in internal medicine, an Assistant Professor of Medicine in the Department of Global Health and Social Medicine at Harvard Medical School, and Associate Physician in the Division of Global Health Equity at Brigham and Women’s Hospital.
Reed Tuckson, M.D., is the managing director of Tuckson Health Connections, a health and medical care consulting business that brings people and ideas together to promote optimal health outcomes. Previously, he enjoyed a long tenure as executive vice president and chief of medical affairs for UnitedHealth Group. Prior to that, Dr. Tuckson’s career includes leadership positions as senior vice president for Professional Standards of the American Medical Association (AMA); President of the Charles R. Drew University of Medicine and Science in Los Angeles; senior vice president for Programs of the March of Dimes Birth Defects Foundation; and the Commissioner of Public Health for the District of Columbia.